Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

136 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Co-administration of tenofovir plus protease inhibitor based antiretroviral therapy during sofosbuvir/ledipasvir treatment for HCV infection: Much Ado About Nothing?
Taramasso L, Ricci E, Celesia BM, Bonfanti P, Quirino T, Squillace N, Nicolini LA, Maggi P, Martinelli C, De Socio GV, Di Biagio A; on behalf CISAI Study Group. Taramasso L, et al. Among authors: celesia bm. Clin Res Hepatol Gastroenterol. 2017 Oct;41(5):e76-e79. doi: 10.1016/j.clinre.2017.03.006. Epub 2017 Apr 21. Clin Res Hepatol Gastroenterol. 2017. PMID: 28438572 No abstract available.
Low frequency of skin reactions in a cohort of patients on raltegravir.
Bonfanti P, Ricci E, Molteni C, De Socio GV, Rusconi S, Vichi F, Penco G, Antinori A, Cordier L, Maggi P, Celesia BM, Grosso C, Quirino T. Bonfanti P, et al. Among authors: celesia bm. J Antimicrob Chemother. 2012 Jul;67(7):1800-2. doi: 10.1093/jac/dks096. Epub 2012 Mar 22. J Antimicrob Chemother. 2012. PMID: 22441576 Free article. No abstract available.
96 Week follow-up of HIV-infected patients in rescue with raltegravir plus optimized backbone regimens: a multicentre Italian experience.
Capetti A, Landonio S, Meraviglia P, Di Biagio A, Lo Caputo S, Sterrantino G, Ammassari A, Menzaghi B, Franzetti M, De Socio GV, Pellicanò G, Mazzotta E, Soria A, Meschiari M, Trezzi M, Sasset L, Celesia BM, Zucchi P, Melzi S, Ricci E, Rizzardini G. Capetti A, et al. Among authors: celesia bm. PLoS One. 2012;7(7):e39222. doi: 10.1371/journal.pone.0039222. Epub 2012 Jul 11. PLoS One. 2012. PMID: 22808029 Free PMC article.
Symmetric ambulatory arterial stiffness index and 24-h pulse pressure in HIV infection: results of a nationwide cross-sectional study.
Schillaci G, Maggi P, Madeddu G, Pucci G, Mazzotta E, Penco G, Orofino G, Menzaghi B, Rusconi S, Carenzi L, Celesia BM, Martinelli C, Bonfanti P, De Socio GV; CISAI Study Group. Schillaci G, et al. Among authors: celesia bm. J Hypertens. 2013 Mar;31(3):560-7; discussion 567. doi: 10.1097/HJH.0b013e32835ca949. J Hypertens. 2013. PMID: 23282895
Safety and durability in a cohort of HIV-1 positive patients treated with once and twice daily darunavir-based therapy (SCOLTA Project).
Menzaghi B, Ricci E, Carenzi L, Parruti G, Orofino G, Guastavigna M, Madeddu G, Maggi P, Di Biagio A, Corsi P, Penco G, De Socio G, Martinelli C, Vichi F, Celesia BM, Franzetti M, Grosso C, Molteni C, Bonfanti P, Quirino T. Menzaghi B, et al. Among authors: celesia bm. Biomed Pharmacother. 2013 May;67(4):293-8. doi: 10.1016/j.biopha.2012.12.005. Epub 2012 Dec 26. Biomed Pharmacother. 2013. PMID: 23433852 Clinical Trial.
Four years data of raltegravir-based salvage therapy in HIV-1-infected, treatment-experienced patients: the SALIR-E Study.
Capetti A, Meraviglia P, Landonio S, Sterrantino G, Di Biagio A, Lo Caputo S, Ammassari A, Menzaghi B, De Socio GV, Franzetti M, Soria A, Meschiari M, Sasset L, Pellicanò G, Mazzotta E, Trezzi M, Celesia BM, Melzi S, Carenzi L, Ricci E, Rizzardini G. Capetti A, et al. Among authors: celesia bm. Int J Antimicrob Agents. 2014 Feb;43(2):189-94. doi: 10.1016/j.ijantimicag.2013.10.013. Epub 2013 Nov 15. Int J Antimicrob Agents. 2014. PMID: 24315315
Decreasing cardiovascular risk in HIV infection between 2005 and 2011.
De Socio GV, Parruti G, Ricci E, Maggi P, Celesia BM, Penco G, Martinelli C, Franzetti M, Di Biagio A, Bonfanti P, Pucci G, Schillaci G; CISAI study group. De Socio GV, et al. Among authors: celesia bm. AIDS. 2014 Feb 20;28(4):609-12. doi: 10.1097/QAD.0000000000000181. AIDS. 2014. PMID: 24378754
Muscle symptoms and creatine phosphokinase elevations in patients receiving raltegravir in clinical practice: Results from the SCOLTA project long-term surveillance.
Madeddu G, De Socio GV, Ricci E, Quirino T, Orofino G, Carenzi L, Franzetti M, Parruti G, Martinelli C, Vichi F, Penco G, Dentone C, Celesia BM, Maggi P, Libertone R, Bagella P, Di Biagio A, Bonfanti P; C.I.S.A.I. Group, Italy. Madeddu G, et al. Among authors: celesia bm. Int J Antimicrob Agents. 2015 Mar;45(3):289-94. doi: 10.1016/j.ijantimicag.2014.10.013. Epub 2014 Nov 13. Int J Antimicrob Agents. 2015. PMID: 25476452
Raltegravir-based therapy in a cohort of HIV/HCV co-infected individuals.
Taramasso L, Madeddu G, Ricci E, De Socio GV, Menzaghi B, Orofino G, Passerini S, Franzetti M, Maggi P, Dentone C, Martinelli C, Celesia BM, Penco G, Libertone R, Quirino T, Bonfanti P, Di Biagio A; CISAI Study Group. Taramasso L, et al. Among authors: celesia bm. Biomed Pharmacother. 2015 Feb;69:233-6. doi: 10.1016/j.biopha.2014.12.006. Epub 2014 Dec 12. Biomed Pharmacother. 2015. PMID: 25661363
136 results